IP Library Granted Patent US 11,371,057
Granted Patent B2
US 11,371,057 · App. 16/704,487 · Granted Jun 28, 2022

Methods of using ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant beta vulgaris plants

Inventors: Ruediger Hain (Frankfurt, DE); Gerhard Johann (Burscheid, DE); Guenter Donn (Hofheim, DE)
Assignee: Bayer Intellectual Property GmbH
C12N15/8278A01N25/00A01N43/50A01N43/54A01N43/653A01N43/66A01N43/88A01N43/90C12N15/8274
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,371,057
App. No.
16/704,487
Granted
Jun 28, 2022
Kind
B2
Abstract

Present invention relates to the use of the ALS inhibitor herbicides for controlling unwanted vegetation in ALS inhibitor herbicide tolerant Beta vulgaris plants, more especially, present invention relates to the use of ALS inhibitor herbicides for control of unwanted vegetation in Beta vulgaris , preferably in sugar beet growing areas in which the Beta vulgaris , preferably sugar beet comprise a mutation in codon 1705-1707 of an endogenous ALS gene encoding an ALS protein containing an amino acid that is different from tryptophan at position 569, preferably the tryptophan is substituted by leucine.

Claims (13)

1. A method for controlling unwanted vegetation in a Beta vulgaris growing area, the method comprising

(a) cultivating at least one non-transgenic Beta vulgaris plant comprising a mutation in a position corresponding to position 1705-1707 of an endogenous acetolactate-synthase (ALS) gene of SEQ ID NO:1, thereby encoding an ALS protein containing leucine at position 569 of SEQ ID NO: 2, wherein the mutation is the only mutation in the ALS protein that confers resistance to one or more ALS inhibitor herbicide(s) and wherein the mutation is homozygously present in the endogenous ALS gene; and

(b) applying one or more ALS inhibitor herbicide(s) to the B. vulgaris growing area, wherein the ALS inhibitor herbicide is a combination of foramsulfuron [CAS RN 173159-57-41] (=A1-13) and thiencarbazone-methyl [CAS RN 317815-83-1] (=A2-3) or wherein the ALS inhibitor herbicide is a combination of compound of formula (III) (=A1-87),

and iodosulfuron-methyl-sodium [CAS RN 144550-36-7] (=A1-16).

2. The method according to claim 1 wherein the one or more ALS inhibitor herbicide(s) is applied in combination with at least one non-ALS inhibitor herbicide selected from the group consisting of:

chloridazon, clethodim, clodinafop, clodinafop-propargyl, clopyralid, cycloxydim, desmedipham, dimethenamid, dimethenamid-P, ethofumesate, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-isopropylammonium, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, lenacil, metamitro, phenmedipham, phenmedipham-ethyl, propaquizafop, quinmerac, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, and sethoxydim.

3. The method according to claim 2 , wherein the non-ALS inhibitor herbicide(s) is selected from the group consisting of:

desmedipham, ethofumesate, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-isopropylammonium, lenacil, metamitron, phenmedipham, and phenmedipham-ethyl.

4. The method according to claim 1 comprising applying the one or more ALS inhibitor herbicide(s) alone or in combination with at least one non-ALS inhibitor herbicides), wherein the application of the respective herbicides

(i) takes place jointly or simultaneously, or

(ii) takes place at different times and/or in a plurality of portions (sequential application), in pre-emergence applications followed by post-emergence applications or early post-emergence applications followed by medium or late post-emergence applications.

5. The method according to claim 4 wherein the non-ALS inhibitor herbicide is selected from the group consisting of:

chloridazon, clethodim, clodinafop, clodinafop-propargyl, clopyralid, cycloxydim, desmedipham, dimethenamid, dimethenamid-P, ethofumesate, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-isopropylammonium, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, lenacil, metamitro, phenmedipham, phenmedipham-ethyl, propaquizafop, quinmerac, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, and sethoxydim.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 4, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Reel/Frame 064198/0823 →
CHANGE OF ADDRESS Recorded Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2020
From: HAIN, RUEDIGER; JOHANN, GERHARD; DONN, GUENTER
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 051699/0963 →